Analysts Bullish on Vera Therapeutics (VERA) Amid New Commercial Chief Appointment
Vera Therapeutics Inc. (NASDAQ:VERA) is one of the 13 hot stocks to buy with the highest upside potential.
Vera Therapeutics Inc. (VERA)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 5,888,888 | $236,909,964 | 2.33% | |
| 2. | Deep Track Capital David Kroin | 4,106,067 | $165,187,075 | +46% | 2.7% |
| 3. | Deerfield Management James E. Flynn | 3,722,100 | $149,740,083 | -9% | 1.77% |
| 4. | Kynam Capital Derrick Tang | 3,398,224 | $136,710,552 | -2% | 8.43% |
| 5. | Eversept Partners Kamran Moghtaderi | 2,173,286 | $87,431,296 | -30% | 4.61% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $42.50 | 5,882 | $249,985.00 | 5,882 | 2025-12-11 | Filing | |
| $22.35 | 27,071 | $605,082.87 | 3,596,593 | 2025-06-24 | Filing | |
| $22.35 | 13,536 | $302,552.61 | 1,797,619 | 2025-06-24 | Filing | |
| $20.87 | 139,595 | $2,913,110.34 | 3,569,522 | 2025-06-23 | Filing | |
| $20.87 | 69,798 | $1,456,565.60 | 1,784,083 | 2025-06-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $37.09 | 4,281 | $158,768.59 | 216,744 | 2026-05-12 | Filing | |
| $36.64 | 14,219 | $520,978.47 | 221,025 | 2026-05-12 | Filing | |
| $45.51 | 900 | $40,960.26 | 235,244 | 2026-04-14 | Filing | |
| $44.58 | 7,921 | $353,105.51 | 236,144 | 2026-04-14 | Filing | |
| $43.66 | 14,130 | $616,985.04 | 244,065 | 2026-04-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,088,102 | $204,694,345 | 0% | |
| 2. | 3,363,638 | $135,319,157 | 0% | |
| 3. | 2,793,987 | $112,402,097 | 4.27% | |
| 4. | 2,683,607 | $107,961,510 | 0% | |
| 5. | 2,676,422 | $107,672,471 | 0.01% |
News See All
13 Hot Stocks to Buy with the Highest Upside Potential
On average, equities are expected continue to deliver positive results in 2026, this time with greater breadth across sectors, styles, and regions, compared to the other periods of the recent bull market...
Atacicept’s Potential Approval Drives Favorable Views on Vera Therapeutics (VERA)
Rama believes the shares offer strong upside potential from the current trading range.
17 Biotechnology Stocks with More Than 50% Upside
2025 was a year characterized by both challenges and opportunities for the biotechnology sector.
Vera Therapeutics, Inc. (VERA): A Bull Case Theory
We came across a bullish thesis on Vera Therapeutics, Inc. on Valueinvestorsclub.com by yarak775. In this article, we will summarize the bulls’ thesis on VERA.
Is Vera Therapeutics (VERA) One of the Best High Short Interest Stocks with Biggest Upside Potential?
Vera Therapeutics Inc. (NASDAQ:VERA) is one of the best high short interest stocks with biggest upside potential.
11 Best High Short Interest Stocks With Biggest Upside Potential
On January 27, Sherry Paul, a senior portfolio manager at Morgan Stanley, appeared on CNBC's 'Closing Bell' to discuss whether more volatility is ahead, following a volatile week in the market.
Clinical Success Lifts Vera (VERA) Shares, Boosting Fund Returns
Voya Investment Management’s Voya MidCap Opportunities Fund released its Q4 2025 investor letter, titled “Seeking a More Favorable Risk/Return Trade-off”, outlining a quarter marked by solid market...
Vera Therapeutics, Inc. (VERA) Granted FDA Priority Review For Atacicept
Vera Therapeutics, Inc. (NASDAQ:VERA) is among the 14 best booming stocks to buy right now. On January 7, the company announced that the U.S.
14 Best Booming Stocks to Buy Right Now
In a report released on January 9, Goldman Sachs said that it expects the index to rally 12% in 2026.